Cited by 114Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.

When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease

Avila-Muñoz, Evangelina, Arias, Clorinda·2014·Ageing Research Reviews

DOI 10.1016/j.arr.2014.07.004

Open this paper in CoChat — free account

Abstract

A growing body of research suggests that astrocytes play roles as contributors to the pathophysiology of Alzheimer's disease (AD). Several lines of evidence propose that activated astrocytes produce and release proinflammatory molecules that may be critical for the generation of amyloid-β peptide (Aβ). However, accumulating evidence indicates that Aβ may activate astrocytes, which leads to an increase in cytokines that has been suggested to be a causative factor in the cognitive dysfunction of AD; thus, a vicious circle may be created. Intrinsic inflammatory mechanisms may provide a regulatory system that is capable of influencing the neuronal microenvironment that affects neuronal survival. In this article, we address the evidence surrounding the interactions of dysfunctional astrocytes with neighboring neurons that may initiate a cascade of events that culminates with neuronal injury and the expression of the hallmark lesions of AD. Comprehensive knowledge of the molecular mechanisms underlying the participation of astrocytes in neurodegeneration could aid the development of therapies to restore proper astrocyte function that can be used in AD patients to prevent or alleviate the progression of the disease in a more efficient and comprehensive manner.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2014.07.004

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,184
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Dementia: a public health priority
Acosta, D. M., Krishnamoorthy, E. S., Wortmann, M., Prince, M. J., & Saxena, S. (2012) · Cited by 1,955

Flagged first, then by citations

Show all 211 references

Research works printed but not linked: 1

Zou, 2010, Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons, Neurochem. Int., 56, 577, 10.1016/j.neuint.2009.12.021 · DOI · Paper page

Sorted by citations

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516
“Recent evidence suggests that reactive astrocytes also contribute to neuroinflammatory processes associated with AD pathology [93].”
Background
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 502
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 480
Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
Behl, T., Kaur, D., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Andronie-Cioară, F. L., Toma, M. M., BUNGAU, S. G., & Bumbu, A. G. (2021) · Molecules · doi:10.3390/molecules26123724 · Cited by 340
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
The Translational Significance of the Neurovascular Unit
McConnell, H. L., Kersch, C. N., Woltjer, R. L., & Neuwelt, E. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.760215 · Cited by 314
Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy
Wang, J., Tang, W., Yang, M., Yin, Y., Li, H., Hu, F., Tang, L., Ma, X., Zhang, Y., & Wang, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120784 · Cited by 317
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
Söllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 275
PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions
Sánchez‐Alegría, K., Flores‐León, M., Ávila-Muñoz, E., Rodríguez-Corona, N., & Arias, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123725 · Cited by 211
Self-citation
Neurotrophic and Neuroregenerative Effects of GH/IGF1
Bianchi, V. E., Locatelli, V., & Rizzi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112441 · Cited by 206
Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches
Ahmad, M. H., Fatima, M., & Mondal, A. C. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.034 · Cited by 201
Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease
Beckmann, N. D., Lin, W.-J., Wang, M., Cohain, A. T., Charney, A. W., Wang, P., Ma, W., Wang, Y.-C., Jiang, C., Audrain, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17405-z · Cited by 172
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., Ojalvo, A. G., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 143
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 146
Regulation of astroglia by gonadal steroid hormones under physiological and pathological conditions
Acaz‐Fonseca, E., Ávila-Rodriguez, M., García‐Segura, L. M., & Barreto, G. E. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.002 · Cited by 130
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease
Heras-Sandoval, D., Pedraza‐Chaverrí, J., & Pérez‐Rojas, J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0525-7 · Cited by 126
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Uddin, M. S., Kabir, M. T., Mamun, A. A., Barreto, G. E., Rashid, M., Perveen, A., & Ashraf, G. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106479 · Cited by 120
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Uchoa, M. F., Moser, V. A., & Pike, C. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.001 · Cited by 105
Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice
Huang, H., Wang, L., Cao, M., Marshall, C., Gao, J., Xiao, N., Hu, G., & Xiao, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu116 · Cited by 94
A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy
Taylor, X., Cisternas, P., You, Y., You, Y., Xiang, S., Marambio, Y. G., Zhang, J., Vidal, R., & Lasagna‐Reeves, C. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01900-7 · Cited by 92
Obesity and sex interact in the regulation of Alzheimer's disease
Moser, V. A., & Pike, C. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.021 · Cited by 91
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease
Borroni, E., Bohrmann, B., Grueninger, F., Prinssen, E. P. M., Navé, S., Loetscher, H., Chinta, S. J., Rajagopalan, S., Rane, A., Siddiqui, A., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241653 · Cited by 90
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s disease
Cantarella, G., Benedetto, G. D., Puzzo, D., Privitera, L., Loreto, C., Saccone, S., Giunta, S., Palmeri, A., & Bernardini, R. (2014) · Brain · doi:10.1093/brain/awu318 · Cited by 87
The multifaceted role of astrocyte connexin 43 in ischemic stroke through forming hemichannels and gap junctions
Liang, Z., Wang, X., Hao, Y., Qiu, L., Lou, Y., Zhang, Y., Ma, D., & Feng, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00703 · Cited by 84
Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease
Katsouri, L., Birch, A. M., Renziehausen, A. W. J., Zach, C., Aman, Y., Steeds, H., Bonsu, A., Palmer, E. O. C., Mirzaei, N., Ries, M., et al. (2020) · Glia · doi:10.1002/glia.23759 · Cited by 81
Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS 1 mouse model
Qiao, J., Wang, J., Wang, H., Zhang, Y., Zhu, S., Adilijiang, A., Guo, H., Zhang, R., Guo, W., Luo, G., et al. (2015) · Glia · doi:10.1002/glia.22926 · Cited by 82
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb
Aridas, J. D. S., McDonald, C. A., Paton, M. C. B., Yawno, T., Sutherland, A. E., Nitsos, I., Pham, Y., Ditchfield, M. R., Fahey, M. C., Wong, F. Y., et al. (2015) · The Journal of Physiology · doi:10.1113/jp271104 · Cited by 79
Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease
Więckowska‐Gacek, A., Mietelska‐Porowska, A., Chutorański, D., Wydrych, M., Długosz, J., & Wojda, U. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654509 · Cited by 70
Slow degradation in phagocytic astrocytes can be enhanced by lysosomal acidification
Lööv, C., Mitchell, C. H., Simonsson, M., & Erlandsson, A. (2015) · Glia · doi:10.1002/glia.22873 · Cited by 71
Connexin-Mediated Functional and Metabolic Coupling Between Astrocytes and Neurons
Mayorquin, L. C., Rodríguez, A. V., Sutachan, J. J., & Albarracín, S. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00118 · Cited by 73
Alzheimer’s disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities
Turner, R. C., Lucke-Wold, B. P., Robson, M. J., Lee, J. M., & Bailes, J. E. (2016) · Brain Injury · doi:10.1080/02699052.2016.1193631 · Cited by 73
Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications
Roveta, F., Bonino, L., Piella, E. M., Rainero, I., & Rubino, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211941 · Cited by 79
α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review
Seifar, F., Khalili, M., Khaledyan, H., Moghadam, S. A., Izadi, A., Azimi, A., & Shakouri, S. K. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1386755 · Cited by 67
The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway
Bao, Y., Jiang, L., Chen, H., Zou, J., Liu, Z., & Shi, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430199 · Cited by 60
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 62
Activated endothelial cells induce a distinct type of astrocytic reactivity
Taylor, X., Cisternas, P., Jury, N., Martínez, P., Huang, X., You, Y., Redding‐Ochoa, J., Vidal, R., Zhang, J., Troncoso, J. C., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03237-8 · Cited by 63
SIRT1 as a therapeutic target for Alzheimer’s disease
Wong, S. Y., & Tang, B. L. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0023 · Cited by 59
Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer's disease
Huo, Q., Shi, Y., Qi, Y., Huang, L., Sui, H., & Zhao, L. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2021.112365 · Cited by 58
Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
Joshi, A. U., & Mochly‐Rosen, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.010 · Cited by 57
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Irwin, M. H., Moos, W. H., Faller, D. V., Steliou, K., & Pinkert, C. A. (2016) · Drug Development Research · doi:10.1002/ddr.21294 · Cited by 57
Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes
Konstantinidis, E., Dakhel, A., Beretta, C., & Erlandsson, A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103839 · Cited by 56
Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
Guo, H. W., Cao, H., Cui, X., Zheng, W., Wang, S., Yu, J., & Chen, Z. (2019) · Molecules · doi:10.3390/molecules24091748 · Cited by 54
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 52
Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology
Adams, S. L., Tilton, K., Kozubek, J. A., Seshadri, S., & Delalle, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw056 · Cited by 45
The mechanisms through which auricular vagus nerve stimulation protects against cerebral ischemia/reperfusion injury
Shan, C., Zhao, J., Wang, Z., Zhang, Y., Wang, W., Cheng, A.-F., & Rong, P. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320992 · Cited by 42
Inverse correlation between Alzheimer’s disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?
Li, J., Liu, C., Hu, X., Cai, Y., Ma, C., Luo, X., & Yan, X. (2014) · BMC Neurology · doi:10.1186/s12883-014-0211-2 · Cited by 41
Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes
Daniele, S., Zappelli, E., & Martini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0446-x · Cited by 36
Possible Neuropathology of Sleep Disturbance Linking to Alzheimer’s Disease: Astrocytic and Microglial Roles
Xiao, S., Liu, Y.-J., Wang, L., Sha, Z., Che, X., Yu, Z., & Lee, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.875138 · Cited by 40
3D Microfibrous Scaffolds Selectively Promotes Proliferation and Glial Differentiation of Adult Neural Stem Cells: A Platform to Tune Cellular Behavior in Neural Tissue Engineering
Patel, B. B., Sharifi, F. J., Stroud, D. P., Montazami, R., Hashemi, N. N., & Sakaguchi, D. S. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800236 · Cited by 36
Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease
Rahman, M. S., Uddin, M. S., Rahman, M. A., Samsuzzaman, M., Behl, T., Hafeez, A., Perveen, A., Barreto, G. E., & Ashraf, G. M. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210612051713 · Cited by 38
Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes
Han, X., Yang, L., Du, H., Sun, Q., Wang, X., Cong, L., Liu, X., Yin, L., Li, S., & Du, Y. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0268-5 · Cited by 36
The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.
Meyer, M., Deniselle, M. C. G., Garay, L., Sitruk-Ware, R., Guennoun, R., Schumacher, M., & Nicola, A. D. D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.007 · Cited by 36
Astrocytic changes with aging and Alzheimer's disease‐type pathology in chimpanzees
Munger, E. L., Edler, M. K., Hopkins, W. D., Ely, J. J., ERWIN, J. M., Perl, D. P., Mufson, E. J., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24610 · Cited by 37
White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial
Stephen, R., for the FINGER study group, Solomon, A., Ngandu, T., Levälahti, E., Rinne, J. O., Kemppainen, N. M., Parkkola, R. K., Antikaínen, R., Strandberg, T. E., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200423 · Cited by 38
Cholesterol‐induced astrocyte activation is associated with increased amyloid precursor protein expression and processing
Ávila-Muñoz, E., & Arias, C. (2015) · Glia · doi:10.1002/glia.22874 · Cited by 35
Self-citation
Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology
Wu, Q., Cortez, L. M., Kamali-Jamil, R., Sim, V. L., Wille, H., & Kar, S. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048929 · Cited by 32
DISC1 regulates astrogenesis in the embryonic brain via modulation of RAS/MEK/ERK signaling through RASSF7
Wang, S., Liang, Q., Qiao, H., Li, H., Shen, T., Ji, F., & Jiao, J. (2016) · Development · doi:10.1242/dev.133066 · Cited by 31
Alzheimer’s Disease, Astrocytes and Kynurenines
Dézsi, L., Tuka, B., Martos, D., & Vécsei, L. (2015) · Current Alzheimer Research · doi:10.2174/156720501205150526114000 · Cited by 33
Uptake, Metabolic Effects and Toxicity of Arsenate and Arsenite in Astrocytes
Dringen, R., Spiller, S., Neumann, S., & Koehler, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1570-9 · Cited by 30
Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation
Kakoty, V., Sarathlal, K. C., Kumari, S., Yang, C., Dubey, S. K., Sahebkar, A., Kesharwani, P., & Taliyan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01187-z · Cited by 30
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder
Thomas, S. D., Abdalla, S., Eissa, N., Akour, A. A., Jha, N. K., Ojha, S. K., & Sadek, B. S. (2024) · Pharmaceuticals · doi:10.3390/ph17070831 · Cited by 33
New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
Chatzipieris, F. P., Kokkalis, A., Georgiou, N., Petsas, E., Apostolou, E. V., Vougioukalakis, G. C., & Mavromoustakos, T. (2025) · ACS Omega · doi:10.1021/acsomega.5c00134 · Cited by 32
Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures
Beggiato, S., Borelli, A. C., Ferraro, L., Tanganelli, S., Antonelli, T., & Tomasini, M. C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170699 · Cited by 28
Siegesbeckia Orientalis L. Extract Attenuates Postoperative Cognitive Dysfunction, Systemic Inflammation, and Neuroinflammation
Chu, J. M. T., Xiong, W., Linghu, K., Liu, Y., Zhang, Y., Zhao, G. D., Irwin, M. G., Wong, G. T. C., & Yu, H. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.6.564 · Cited by 27
Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals
Brignone, M. S., Lanciotti, A., Serafini, B., Mallozzi, C., Sbriccoli, M., Veroni, C., Molinari, P., Elorza‐Vidal, X., Petrucci, T. C., Estévez, R., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01657-y · Cited by 28
Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis
Wang, J., Liu, B., Xu, Y. X., Luan, H., Wang, C., Yang, M., Zhao, R., Song, M., Liu, J., Sun, L., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113870 · Cited by 26
The Efficacy and Underlying Mechanism of Moxibustion in Preventing Cognitive Impairment: A Systematic Review of Animal Studies
Choe, S., Cai, M., Jerng, U. M., & Lee, J. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.1.1 · Cited by 23
Inhibition of Enzymes Involved in Neurodegenerative Disorders and Aβ1–40 Aggregation by Citrus limon Peel Polyphenol Extract
Arcone, R., D’Errico, A., Nasso, R., Rullo, R., Poli, A., Donato, P. D., & Masullo, M. (2023) · Molecules · doi:10.3390/molecules28176332 · Cited by 22
Tanshinone IIA decreases the levels of inflammation induced by Aβ1–42 in brain tissues of Alzheimer’s disease model rats
Lu, B.-L., Li, J., Zhou, J., Li, W., & Wu, H.-F. (2016) · Neuroreport · doi:10.1097/wnr.0000000000000618 · Cited by 21
Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression
Escudero‐Lourdes, C., Uresti‐Rivera, E. E., Oliva-González, C., Torres-Ramos, M., Aguirre-Bañuelos, P., & Gandolfi, A. J. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1968-z · Cited by 20
Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease
Ferguson, S. A., Varma, V., Sloper, D. T., Panos, J., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00512-2 · Cited by 18
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury
Gleixner, A. M., Posimo, J. M., Pant, D. B., Henderson, M. P., & Leak, R. K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9427-4 · Cited by 19
Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders
Mehan, S., Jadaun, K. S., Sharma, A., & Siddiqui, E. M. (2021) · Current Clinical Pharmacology · doi:10.2174/1574884716666210726110021 · Cited by 19
Neurobiological role and therapeutic potential of exercise-induced irisin in Alzheimer's disease management
Ratne, N., Jari, S., Tadas, M., Katariya, R., Kale, M. B., Kotagale, N. R., Madia, D., Umekar, M. J., & Taksande, B. G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102687 · Cited by 17
The Effect of Aβ1-42 Oligomers on APP Processing and Aβ1-40 Generation in Cultured U-373 Astrocytes
Ourdev, D., Foroutanpay, B. V., Wang, Y., & Kar, S. (2015) · Neurodegenerative Diseases · doi:10.1159/000438923 · Cited by 16
Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 transgenic mice
Ding, L., Meng, Y., Zhang, H., Yin, W., Yan, Y., & Cao, Y. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.01.003 · Cited by 15
Increased CSF tau level is correlated with decreased lamina cribrosa thickness
Lee, E. J., Kim, T., Lee, D. S., Kim, H., Park, Y. H., Kim, J.-E., Lee, J. W., & Kim, S. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0169-3 · Cited by 15
C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively
Xie, H., Xiao, Z., & Huang, J. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0690-7 · Cited by 15
Paeoniflorin ameliorates Aβ-stimulated neuroinflammation via regulation of NF-κB signaling pathway and Aβ degradation in C6 glial cells
Cho, E. J., Kim, H. Y., & Lee, A. Y. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.6.593 · Cited by 14
Neuroinflammation and Oxidative Stress in Alzheimer’s Disease; Can Nutraceuticals and Functional Foods Come to the Rescue?
Onaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss
Snow, A. D., Cummings, J. A., Tanzi, R. E., & Lake, T. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-79275-1 · Cited by 14
Multiscale causal network models of Alzheimer’s disease identify VGF as a key regulator of diseasePreprint
Beckmann, N., Lin, W.-J., Wang, M.-H., Cohain, A., Wang, P., Ma, W., Wang, Y.-C., Jiang, C., Audrain, M., Comella, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/458430 · Cited by 12
Effects of Current Psychotropic Drugs on Inflammation and Immune System
Bhatt, S., Dhar, A. K., Samanta, M. K., & Suttee, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_18 · Cited by 12
Fluorescence method for monoamine oxidase B detection based on the cage function of glyoxal and phenethylamine on G-rich DNA
Wang, X., Song, X., Li, P., Sun, S., Mao, J., Liu, S., & Wei, W. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132624 · Cited by 9
Conditioned Medium Derived from Salidroside-Pretreated Mesenchymal Stem Cell Culture Ameliorates Mouse Lipopolysaccharide-Induced Cerebral Neuroinflammation- Histological and Immunohistochemical Study
Maadawi, Z. M. E. (2017) · International Journal of Stem Cells · doi:10.15283/ijsc16055 · Cited by 9
Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases
Khairallah, M. I., Kassem, L. A., Yassin, N. A. E., el Din, M. A. G., Zekri, M., & Attia, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.007 · Cited by 8
Cannabidiol‐Rich Cannabis sativa L. Extract Alleviates LPS ‐Induced Neuroinflammation Behavioral Alterations, and Astrocytic Bioenergetic Impairment in Male Mice
Ibork, H., lhaj, Z. A., Boualam, K., Idrissi, S. E., Ortaakarsu, A. B., Hajji, L., Morgan, A. M., Khallouki, F., Taghzouti, K., & Abboussi, O. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70035 · Cited by 8
Astrocytes’ Role in Alzheimer’s Disease Neurodegeneration
Prà, I. D., Armato, U., & Chiarini, A. (2018) · InTech eBooks · doi:10.5772/intechopen.72974 · Cited by 7
Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer’s disease via modulating neuropathology and gut microbiota
Zhong, M., Xu, Q., Huang, M., Zhan, R., Huang, X., Yang, W., Lin, Z., & Xian, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01475-0 · Cited by 9
Oxidative Stress and the Role of Immune Cells in Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
Puranik, N., & Song, M. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273355336250226055826 · Cited by 8
Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
Molecular mechanism underlying stress response and adaptation
Yusuf, J. A., Akanbi, S. T., Olorunlowu, D. R., Opoola, E. K., Ogunlade, E. E., Kayode, E. A., Adejobi, E. O., Sulaiman, Y. O., Odemakinde, D. I., Aworeni, E. O., et al. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.01.005 · Cited by 5
An Aβ3‑10‑KLH vaccine decreases Aβ plaques and astrocytes and microglia activation in the brain of APP/PS1 transgenic mice
Wang, Y., Xu, B., Zhou, J., Wang, J., Wang, G., & Cao, Y. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-020 · Cited by 5

Authors: Avila-Muñoz, E., & Arias, C.
Affiliations: Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (MX)
Corresponding author: Arias, Clorinda
ORCID: Arias, Clorinda
Venue: Ageing Research Reviews
Publisher: Elsevier BV
Published: 2014-11
Volume: 18
Pages: 29-40
ISSN: 1568-1637 (ISSN-L)
DOI: 10.1016/j.arr.2014.07.004
OpenAlex: W2017431945
Cited by: 114
References: 211
Citations by year: 2026: 4 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 13 · 2020: 10 · 2019: 6 · 2018: 10 · 2017: 8 · 2016: 19 · 2015: 20 · 2014: 2
FWCI: 1.91
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Ageing Research Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: CONACYT (166482, 239696)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: astrocytes, Alzheimer's disease, neuroinflammation, amyloid-beta, cytokines, astrocyte-neuron interaction, neurodegeneration, cognitive impairment, neuronal injury, astrocyte dysfunction
MeSH terms: Alzheimer Disease, Animals, Astrocytes, Humans, Inflammation, Neurons, Signal Transduction, Amyloid beta-Peptides, Inflammation Mediators, Paracrine Communication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks